Healthcare provider profile · identity verified

Molly Imber, MD

Allopathic & Osteopathic Physicians|Internal Medicine · LAWRENCE, KS · NPI 1407076987

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Molly Imber, MD received $57.18 in general payments during 2025 across 3 reported records.

Dexcom, Inc. accounted for 39.8% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 5 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis, Mounjaro.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Mounjaro by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 29 claims for Trulicity by this doctor in 2024.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 235 claims for Eliquis by this doctor in 2024.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 22 claims for Paxlovid by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$57.18

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Dexcom, Inc.	Unresolved — no canonical attribution shown	$22.74	39.8%	1	2025
Lilly USA, LLC	Unresolved — no canonical attribution shown	$20.89	36.5%	1	2025
PFIZER INC.	Unresolved — no canonical attribution shown	$13.55	23.7%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$57.18	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Dexcom G6 Transmitter Normalized: dexcom g6 transmitter	Medical Supply	Dexcom, Inc.	$22.74	1	2025
Source payment records 2025-11-03 · Dexcom, Inc. · $22.74 · Open Payments source
MOUNJARO Normalized: mounjaro	Drug	Lilly USA, LLC	$20.89	1	2025
Source payment records 2025-09-23 · Lilly USA, LLC · $20.89 · Open Payments source
ZEPBOUND Normalized: zepbound	Drug	Lilly USA, LLC	$20.89	1	2025
Source payment records 2025-09-23 · Lilly USA, LLC · $20.89 · Open Payments source
ELIQUIS Normalized: eliquis	Drug	PFIZER INC.	$13.55	1	2025
Source payment records 2025-12-16 · PFIZER INC. · $13.55 · Open Payments source
NURTEC ODT Normalized: nurtec odt	Drug	PFIZER INC.	$13.55	1	2025
Source payment records 2025-12-16 · PFIZER INC. · $13.55 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
ELIQUIS eliquis	2025	Eliquis	2024	235	exact normalized	Medicare Part D
MOUNJARO mounjaro	2025	Mounjaro	2024	26 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	26	suppressed by CMS
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	29	suppressed by CMS
PFIZER INC. Exact reporting entity; no affiliate inference	2025	ELIQUIS open payments reported associated product	CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063	Eliquis · 2024 Exact normalized brand match · 1 Part D row	235	35
PFIZER INC. Exact reporting entity; no affiliate inference	2025	PAXLOVID open payments reported associated product	CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432	Paxlovid · 2024 Exact normalized brand match · 1 Part D row	22	21

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	788	166
Atorvastatin Calcium	Atorvastatin Calcium	627	150
Amlodipine Besylate	Amlodipine Besylate	562	136
Lisinopril	Lisinopril	520	138
Losartan Potassium	Losartan Potassium	495	126
Omeprazole	Omeprazole	471	113
Hydrochlorothiazide	Hydrochlorothiazide	348	95
Gabapentin	Gabapentin	261	58
Eliquis	Apixaban	235	35
Simvastatin	Simvastatin	232	55
Escitalopram Oxalate	Escitalopram Oxalate	206	51
Metoprolol Succinate	Metoprolol Succinate	205	47
Meloxicam	Meloxicam	204	45
Rosuvastatin Calcium	Rosuvastatin Calcium	176	49
Trazodone Hcl	Trazodone Hcl	175	40
Sertraline Hcl	Sertraline Hcl	172	46
Carvedilol	Carvedilol	171	35
Metformin Hcl	Metformin Hcl	145	40
Alendronate Sodium	Alendronate Sodium	136	40
Pantoprazole Sodium	Pantoprazole Sodium	133	36
Potassium Chloride	Potassium Chloride	133	37
Pravastatin Sodium	Pravastatin Sodium	131	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	125	24
Citalopram Hbr	Citalopram Hydrobromide	122	26
Fluticasone Propionate	Fluticasone Propionate	114	35
Clopidogrel	Clopidogrel Bisulfate	104	24
Furosemide	Furosemide	103	25
Famotidine	Famotidine	98	16
Donepezil Hcl	Donepezil Hcl	97	21
Albuterol Sulfate Hfa	Albuterol Sulfate	96	26
Allopurinol	Allopurinol	93	20
Mirtazapine	Mirtazapine	89	20
Buspirone Hcl	Buspirone Hcl	88	21
Oxybutynin Chloride Er	Oxybutynin Chloride	85	19
Olmesartan Medoxomil	Olmesartan Medoxomil	76	13
Atenolol	Atenolol	74	17
Alprazolam	Alprazolam	73	29
Duloxetine Hcl	Duloxetine Hcl	68	15
Ozempic	Semaglutide	68	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	66	14
Metoprolol Tartrate	Metoprolol Tartrate	64	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	60	17
Montelukast Sodium	Montelukast Sodium	60	16
Memantine Hcl Er	Memantine Hcl	58	12
Prednisone	Prednisone	58	39
Glimepiride	Glimepiride	54	11
Tramadol Hcl	Tramadol Hcl	53	15
Xarelto	Rivaroxaban	53	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	14
Tamsulosin Hcl	Tamsulosin Hcl	52	15
Clonazepam	Clonazepam	51	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	50	11
Spironolactone	Spironolactone	50	15
Diclofenac Sodium	Diclofenac Sodium	48	15
Fluoxetine Hcl	Fluoxetine Hcl	48	11
Zolpidem Tartrate	Zolpidem Tartrate	47	16
Venlafaxine Hcl Er	Venlafaxine Hcl	46	11
Irbesartan	Irbesartan	42	suppressed
Ondansetron Odt	Ondansetron	41	16
Triamcinolone Acetonide	Triamcinolone Acetonide	41	24
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	suppressed
Estradiol	Estradiol	40	17
Nortriptyline Hcl	Nortriptyline Hcl	39	suppressed
Bupropion Xl	Bupropion Hcl	38	12
Synthroid	Levothyroxine Sodium	38	suppressed
Pregabalin	Pregabalin	37	suppressed
Acyclovir	Acyclovir	36	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	suppressed
Myrbetriq	Mirabegron	36	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Baclofen	Baclofen	35	suppressed
Lovastatin	Lovastatin	35	suppressed
Solifenacin Succinate	Solifenacin Succinate	35	suppressed
Ipratropium Bromide	Ipratropium Bromide	34	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	33	27
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Valacyclovir	Valacyclovir Hcl	33	12
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	15
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Nystatin	Nystatin	30	20
Celecoxib	Celecoxib	29	12
Trulicity	Dulaglutide	29	suppressed
Bumetanide	Bumetanide	26	suppressed
Lorazepam	Lorazepam	26	11
Mounjaro	Tirzepatide	26	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Fluconazole	Fluconazole	25	15
Ondansetron Hcl	Ondansetron Hcl	25	12
Quetiapine Fumarate Er	Quetiapine Fumarate	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Novolog Flexpen	Insulin Aspart	24	suppressed
Trospium Chloride Er	Trospium Chloride	24	suppressed
Liothyronine Sodium	Liothyronine Sodium	23	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	22	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	21
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	12
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	18
Cephalexin	Cephalexin	19	suppressed
Clonidine	Clonidine	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Diazepam	Diazepam	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Telmisartan	Telmisartan	18	suppressed
Rivastigmine	Rivastigmine	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	16
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Colchicine	Colchicine	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Morphine Sulfate	Morphine Sulfate	16	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	14	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	11
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Lactulose	Lactulose	13	suppressed
Paroxetine Cr	Paroxetine Hcl	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Hydroxyurea	Hydroxyurea	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Amiloride Hcl	Amiloride Hcl	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Budesonide Dr	Budesonide	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Movantik	Naloxegol Oxalate	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Restasis	Cyclosporine	11	suppressed
Risperidone	Risperidone	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$57.18 · 3 records	Dexcom, Inc.	Dexcom G6 Transmitter, ELIQUIS, MOUNJARO, NURTEC ODT, ZEPBOUND	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Eliquis play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error